Processing, please wait...
VOLTAR

IMCAS World Congress 2025
Programa


Lasers - Contributed talks

Sala: Room 153 - Level 1
Data: quinta-feira 30 janeiro 2025 de 10:00 às 12:30
Formato: PALESTRAS CONTRIBUÍDAS > sessão composta por resumos submetidos que foram cuidadosamente revisados e selecionados pelo Conselho Científico

Moderadores

Prof Ashraf BADAWI
Dermatologista
Canadá
Dr Christine DIERICKX
Dermatologista
Luxemburgo
Dr Martin KASSIR
Dermatologista
Estados Unidos da América
Dr Fabian PEREZ RIVERA
Cirurgião Plástico
Argentina

Apresentações desta sessão

Horas Palestrantes Título da apresentação Resumo Número
10:00 Epigenetic modifications post 1940nm non-ablative fractionated laser treatment: A split-face clinical investigation Visualizar 140838
10:10 Laser pre-treatment for the attenuation of planned surgical scars Visualizar 140839
10:20 Real world experience with a new 675nm laser for treatment of keloids and hypertrophic scars Visualizar 140840
10:30 Early managing of complications after surgical blepharoplasty using an Er:YAG laser Visualizar 140842
10:40 Fractional lasers: Benefits and optimization in skin of color patients Visualizar 140843
10:50 A real-world study of pulsed dye laser for the treatment of inflammatory acne vulgaris in adult females Visualizar 140844
11:00 Long-term satisfaction with CO2 laser treatment for rhinophyma: A single-center study Visualizar 140845
11:10 Easily treated common pigmented papillae of the tongue using the Q-switched ruby and pico lasers Visualizar 140846
11:20 Split-face evaluation: Transdermal delivery of human umbilical cord stem cell-derived exosomes via micro-needling versus fractional CO2 laser Visualizar 140847
11:30 Efficacy and safety of picoseconds laser 1,064 nm in treatment of periorbital hyper melanosis in Fitzpatrick skin type IV Visualizar 140848
11:40 Periocular rejuvenation with new fractional hybrid laser double pass technique Visualizar 140850
11:50 Laser and melasma: What's new? Visualizar 140851
12:00 Lasers in treating scars in skin of color 144818
12:10 Discussion and Q&A 140852